BlackRock »

Tonix Pharmaceuticals Hldg C shares owned by BlackRock

Quarter-by-quarter ownership of Tonix Pharmaceuticals Hldg C shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Tonix Pharmaceuticals Hldg C

Tip: Access up to 7 years of quarterly data

All positions including Tonix Pharmaceuticals Hldg C held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tonix Pharmaceuticals Hldg C by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $884 1.3k 0.70

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Tonix Pharmaceuticals Hldg C

Alyeska Investment Group
Acadian Asset Management
Vanguard Group
Hrt Financial
Geode Capital Management
Jane Street
Tower Research Capital
BlackRock
Qube Research & Technologies
Morgan Stanley
Bank of America Corporation
Bnp Paribas Arbitrage, Snc
Jpmorgan Chase & Co
NVWM
Royal Bank of Canada

View all funds holding Tonix Pharmaceuticals Hldg C